Table 5.
Screening history1 | No. of case sub. | No. of control sub. | OR | OR adjusted2 | Stage distribution of cases | |||
---|---|---|---|---|---|---|---|---|
Stage IA (%) | Stage IB (%) | Stage II+ (%) | PropOR (95%CI)3 | |||||
Nor.–Nor. | 651 | 48,742 | Ref. | Ref. | 116 (17.8) | 343 (52.7) | 192 (29.5) | Ref. |
Abn.–Nor. | 85 | 1,605 | 4.1 (3.2–5.1) | 4.0 (3.2–5.1) | 19 (22.4) | 45 (52.9) | 21 (24.7) | 0.8 (0.5–1.2) |
Abn.–Unscr. | 84 | 283 | 24.1 (18.6–31.1) | 23.7 (18.3–30.7) | 21 (25.0) | 34 (40.5) | 29 (34.5) | 1.0 (0.7–1.6) |
Nor.–Abn. | 237 | 1,166 | 15.4 (13.1–18.0) | 15.3 (13.1–18.0) | 89 (37.6) | 119 (50.2) | 29 (12.2) | 0.4 (0.3–0.6) |
Unscr.–Abn. | 128 | 474 | 21.3 (17.2–26.3) | 21.1 (17.1–26.1) | 52 (40.6) | 51 (39.8) | 25 (19.5) | 0.5 (0.3–0.7) |
Abn.–Abn. | 72 | 316 | 17.5(13.4–22.8) | 17.4(13.3–22.8) | 25 (34.7) | 36 (50.0) | 11 (15.3) | 0.5 (0.3–0.8) |
Left‐hand side of hyphen represents the previous screening round, and right‐hand side represents the most recent screening round.
Adjusted for education and age group.
Proportional odds ratio, measuring the risk of being diagnosed with progressively higher staged cervical cancer, adjusted for age group.
Abbreviations: Abn., abnormal; Nor., normal; Unscr., unscreened.